United States · FDA National Drug Code directory
OLANZAPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-166_1a64829a-2434-4c8d-8e58-9b28758e4b88
- Product NDC
- 13668-166
- Form
- TABLET
- Composition / generic term
- OLANZAPINE
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260228
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (13668-166-01) · 13668-166-01
- 500 TABLET in 1 BOTTLE (13668-166-05) · 13668-166-05
- 1000 TABLET in 1 BOTTLE (13668-166-10) · 13668-166-10
- 30 TABLET in 1 BOTTLE (13668-166-30) · 13668-166-30
- 3000 TABLET in 1 BOTTLE (13668-166-43) · 13668-166-43
- 60 TABLET in 1 BOTTLE (13668-166-60) · 13668-166-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →